Patent trial over Amgen's white blood cell drug Neulasta wraps up

A federal judge in Fort Lauderdale, Florida on Monday heard closing arguments in a patent lawsuit brought by Amgen Inc in an effort to block Apotex Inc from launching a copycat version of its white-blood-cell-boosting drug Neulasta.

http://www.reuters.com/article/health-neulasta-idUSL1N1A50AC